Last updated on June 2019

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers


Brief description of study

Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of avatrombopag in subjects with chemotherapy-induced thrombocytopenia receiving chemotherapy for the treatment of ovarian, lung (small cell and non-small cell) and bladder cancer.

Detailed Study Description

Subjects will receive placebo controlled test treatment for one cycle of chemotherapy followed by an observational cycle. Subjects will have the option to continue into an open label extension period for all remaining chemotherapy cycles within the current regimen. After the follow-up visit, all subjects will continue to a long-term safety follow-up period.

Clinical Study Identifier: NCT03471078

Find a site near you

Start Over

Dova Site

Anaheim, CA United States
  Connect »

Dova Site

Bakersfield, CA United States
  Connect »

Dova Site

Beverly Hills, CA United States
  Connect »

Dova Site

Riverside, CA United States
  Connect »

Dova Site

Santa Monica, CA United States
  Connect »

Dova Site

Augusta, GA United States
  Connect »

Dova Site

Harvey, IL United States
  Connect »

Dova Site

Skokie, IL United States
  Connect »

Dova Site

Bloomington, IN United States
  Connect »

Dova Site

Wichita, KS United States
  Connect »

Dova Site

Ashland, KY United States
  Connect »

Dova Site

Minneapolis, MN United States
  Connect »

Dova Site

New York, NY United States
  Connect »

Dova Site

Canton, OH United States
  Connect »

Dova Site

Gettysburg, PA United States
  Connect »

Dova Site

Budapest, Hungary
  Connect »

Dova Site

Debrecen, Hungary
  Connect »

Dova Site

Nyiregyhaza, Hungary
  Connect »

Dova Site

Törökbálint, Hungary
  Connect »

Dova Site

Gdynia, Poland
  Connect »

Dova Site

Kielce, Poland
  Connect »

Dova Site

Lublin, Poland
  Connect »

Dova Site

Olsztyn, Poland
  Connect »

Dova Site

Prabuty, Poland
  Connect »

Dova Site

Tomaszów Mazowiecki, Poland
  Connect »

Dova Site

Warsaw, Poland
  Connect »

Dova Site

Arkhangel'sk, Russian Federation
  Connect »

Dova Site

Ivanovo, Russian Federation
  Connect »

Dova Site

Kaluga, Russian Federation
  Connect »

Dova Site

Kazan, Russian Federation
  Connect »

Dova Site

Kursk, Russian Federation
  Connect »

Dova Site

Kuz'molovskiy, Russian Federation
  Connect »

Dova Site

Moscow, Russian Federation
  Connect »

Dova Site

Novosibirsk, Russian Federation
  Connect »

Dova Site

Omsk, Russian Federation
  Connect »

Dova Site

Pyatigorsk, Russian Federation
  Connect »

Dova Site

Saint Petersburg, Russian Federation
  Connect »

Dova Site

Saransk, Russian Federation
  Connect »

Dova Site

Belgrade, Serbia
  Connect »

Dova Site

Kragujevac, Serbia
  Connect »

Dova Site

Cherkasy, Ukraine
  Connect »

Dova Site

Chernihiv, Ukraine
  Connect »

Dova Site

Chernivtsi, Ukraine
  Connect »

Dova Site

Ivano-Frankivs'k, Ukraine
  Connect »

Dova Site

Kharkiv, Ukraine
  Connect »

Dova Site

Kherson, Ukraine
  Connect »

Dova Site

Kyiv, Ukraine
  Connect »

Dova Site

Odesa, Ukraine
  Connect »

Dova Site

Sumy, Ukraine
  Connect »

Dova Site

Ternopil', Ukraine
  Connect »

Dova Site

Uzhhorod, Ukraine
  Connect »

Dova Site

Vinnytsia, Ukraine
  Connect »

Dova Site

Törökbálint, Hungary
  Connect »

Dova Site

Tomaszów Mazowiecki, Poland
  Connect »

Dova Site

Boston, MA United States
  Connect »

Dova Site

Törökbálint, Hungary
  Connect »

Dova Site

Tomaszów Mazowiecki, Poland
  Connect »

Dova Site

Törökbálint, Hungary
  Connect »

Dova Site

Tomaszów Mazowiecki, Poland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.